Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

First Episode Psychosis and Pathway to Care in Nordland

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified December 2012 by Nordlandssykehuset HF
Sponsor:
Information provided by (Responsible Party):
Nordlandssykehuset HF
ClinicalTrials.gov Identifier:
NCT01753284
First received: December 17, 2012
Last updated: December 19, 2012
Last verified: December 2012
  Purpose

First episode psychosis patients often experiences treatment delay. This reduces their prospects for recovery and makes unnecessary burdens for them and their carers. A better understanding of help seeking intentions is required, and has not been explored in a county like Nordland, Norway, with long distances and challenging access to health services. The purpose of this study is to explore the process of help seeking, including how patients and their careers discover and understand the psychotic symptoms. Research exploring the impact on families mainly focuses on parents` experiences, and there are less studies focusing on experiences and needs of siblings. This study will therefore explore siblings` experiences separate from their parents. Methods will be qualitative interviews with patients, their carers and siblings. Analysis will be influenced by Grounded theory.


Condition
First Episode Psychosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Patients and Carers Experiences With First Episode Psychosis and Pathway to Care in Nordland: A Qualitative Study

Resource links provided by NLM:


Further study details as provided by Nordlandssykehuset HF:

Primary Outcome Measures:
  • Patient experience [ Time Frame: up to 100 weeks ] [ Designated as safety issue: No ]
  • Carers experiences [ Time Frame: up to 100 weeks ] [ Designated as safety issue: No ]
  • Siblings experiences [ Time Frame: up to 100 weeks ] [ Designated as safety issue: No ]
  • Pathway to care [ Time Frame: up to 100 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: January 2013
Estimated Study Completion Date: January 2015
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   16 Years to 35 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients experiencing first and multiple episode psychosis carers siblings

Criteria

Inclusion Criteria:

  • age 16-35,
  • understand and speak Norwegian
  • able to give consent
  • no learning disabilities

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Nordlandssykehuset HF
ClinicalTrials.gov Identifier: NCT01753284     History of Changes
Other Study ID Numbers: 2012/1650(REK)
Study First Received: December 17, 2012
Last Updated: December 19, 2012
Health Authority: Norway:National Committee for Medical and Health Research Ethics
Norway: Data Protection Authority
Norway: Directorate of Health

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on November 24, 2014